Elaitra
San Francisco
About Elaitra
Elaitra’s breast cancer platform includes a Generative LLM for voice-based patient engagement, and a unique AI reading tool that helps doctors read 3D X-Rays. Operating in USA & UK. FDA 510(k) and UK regulator approved.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.0M
- Funding stage: Seed
- Last round: Pre-Seed (Jun 2023)
- Website: elaitra.net
- Phone: +1-347-796-4466, +44-7771-806-100
Industries & Categories
Artificial Intelligence (AI), Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/elaitra-9629 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.